CA
NZ
UK
AU
IND
US
VEON Ltd. (Nasdaq:VEON), a global digital operator serving millions of users across multiple markets, has initiated the USD 100 millionbuybackprogram previously announced on November 10, 2025. The initiative authorizes VEON to repurchase American Depositary Shares and/or outstanding bonds, with the allocation betweenequityanddebtguided by prevailing …
Incyte(NASDAQ:INCY) has announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion recommending approval ofMinjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adults with relapsed or refractory follicular lymphoma after at least one …
HighlightsViasat plans to integrate Telesat Lightspeed LEO capacity into its JetXP service beginning in late 2027.The multi-orbit architecture will combine GEO, LEO, and future HEO payloads for enhanced global coverage.JetXP users will benefit from improved performance for applications like gaming, HD video conferencing, and …
Sohu.com Limited (NASDAQ:SOHU) reported a meaningful turnaround in the third quarter of 2025, fueled by accelerated momentum in its online game portfolio. Total revenues reached USD 180 million, an increase of 19% year-over-year and 43% quarter-over-quarter. Online game revenues accounted for USD 162 million …
Beneficient (Nasdaq:BENF) released its fiscal second quarter 2026 results, highlighting meaningful progress in cost discipline,capital structurealignment, and regulatory compliance. Interim CEO James Silk emphasized that the quarter marked a pivotal phase for the company, with a renewed focus on execution,liquidityimprovement, and operational efficiency.
Prairie Operating Co. (NASDAQ:PROP) delivered another impactful quarter as it continued scaling its presence in the Denver-Julesburg Basin following itsacquisitionof Bayswater Exploration & Productionassets. The company posted record production levels of 23,029 Boe/d in Q3 2025, with volumes comprising approximately 52% oil and 72% …
Predictive Oncology(POAI:NASDAQ)entered Q3 2025 with a focus on transforming its business model by integrating a digitalassetstrategy into its traditionalAI-driven drug discovery platform. The centerpiece of this expansion is the company’s treasury strategy centered on ATH, the native utility token of the Aethir ecosystem. Two …
Waldencast plc(NASDAQ:WALD)has taken a significant financial step with the sale of its rights to the “Obagi” trademark in Japan to Rohto Pharmaceutical Co., Ltd. for USD 82.5 million. Rohto has held the license for the “Obagi” mark in Japan since 2002 and over the …
Eledon Pharmaceuticals (NASDAQ:ELDN) released its third quarter 2025 update, highlighting significant clinical, regulatory, and financial developments. Central to the announcement were the encouraging results from the Phase 2 BESTOW trial, which evaluated tegoprubart as a potential alternative to traditional immunosuppressive therapies in kidney transplantation. …
Trevi Therapeutics (NASDAQ:TRVI) has received a series of updates from research firms in recent days. D. Boral Capital reaffirmed its "buy" rating on the stock with a target price of $19.00, suggesting a potential upside from the stock's most recent close. This aligns with …
Please wait processing your request...